CMMB
Chemomab Therapeutics Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$2.71
−4.24%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-87.5%
Return on equity
-74.3%
Return on assets
-91.7%
Return on invested capital
0.00x
Asset turnover
-$11.2M
Cash from operations
$0.91
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026